John T Chang Selected Research

Immunoglobulin G (IgG)

3/2015

Immunodeficiency and autoimmune enterocolopathy linked to NFAT5 haploinsufficiency.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

John T Chang Research Topics

Disease

10	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2022 - 04/2006
9	Ulcerative Colitis 10/2023 - 09/2014
6	Crohn Disease (Crohn's Disease) 01/2021 - 09/2014
5	Inflammation (Inflammations) 12/2023 - 03/2015
4	Bacterial Infections (Bacterial Infection) 12/2023 - 01/2017
4	Infections 10/2020 - 03/2015
3	Virus Diseases (Viral Diseases) 09/2023 - 01/2017
3	Colitis 01/2022 - 01/2017
2	Colitis-Associated Neoplasms 12/2023 - 02/2023
2	Breast Neoplasms (Breast Cancer) 01/2018 - 10/2015
1	Persistent Infection 01/2023
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2023
1	Reinfection 10/2020
1	Cystic Fibrosis (Mucoviscidosis) 01/2020
1	Hemorrhage 10/2018
1	Genetic Risk Score 01/2018
1	Dysbiosis 01/2018
1	Neoplasm Metastasis (Metastasis) 01/2018
1	Shock 01/2018
1	Carcinoma (Carcinomatosis) 04/2016
1	Neoplasms (Cancer) 04/2016
1	Classical Lissencephalies and Subcortical Band Heterotopias 01/2016
1	Intestinal Polyposis (Polyposis, Intestinal) 01/2016
1	Colorectal Neoplasms (Colorectal Cancer) 03/2015
1	Botulism 01/2015
1	Rheumatoid Arthritis 09/2014
1	Toxic Megacolon 12/2012
1	Autoimmune Diseases (Autoimmune Disease) 07/2011
1	Thyroid Neoplasms (Thyroid Cancer) 11/2010
1	Osteoarthritis 04/2006
1	Adenocarcinoma 07/2004
1	Barrett Esophagus (Barrett's Esophagus) 07/2004
1	Asthma (Bronchial Asthma) 05/2004
1	Heart Failure 05/2004
1	Pain (Aches) 05/2004
1	Stroke (Strokes) 11/2003

Drug/Important Bio-Agent (IBA)

6	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2017
5	vedolizumabIBA 10/2023 - 01/2016
3	Interleukin-10 (Interleukin 10)IBA 01/2022 - 01/2017
2	Interleukin-27 (Interleukin 27)IBA 12/2023 - 02/2023
2	IntegrinsIBA 10/2023 - 07/2011
2	AntigensIBA 10/2020 - 01/2020
2	Biomarkers (Surrogate Marker)IBA 10/2019 - 02/2015
2	CytokinesIBA 03/2015 - 02/2015
1	EpitopesIBA 10/2023
1	UbiquinoneIBA 09/2023
1	Interleukin-2 (IL2)IBA 01/2023
1	Tumor Necrosis Factor InhibitorsIBA 01/2023
1	COVID-19 VaccinesIBA 01/2022
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2022
1	VaccinesIBA 01/2022
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 11/2021
1	Hyaluronoglucosaminidase (Hyaluronidase)FDA Link 11/2021
1	Dextrans (Dextran)FDA Link 11/2021
1	Bile Acids and Salts (Bile Acids)IBA 01/2020
1	Antigen Receptors (Antigen Receptor)IBA 01/2020
1	Small Cytoplasmic RNAIBA 01/2020
1	salicylhydroxamic acid (SHAM)IBA 10/2018
1	NucleotidesIBA 01/2018
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2018
1	Phenobarbital (Luminal)FDA Link 01/2018
1	Virulence Factors (Pathogenicity Factors)IBA 01/2018
1	Transforming Growth Factor-beta Type II ReceptorIBA 01/2018
1	Caspase 3 (Caspase-3)IBA 01/2018
1	ChromatinIBA 01/2017
1	Ion Channels (Ion Channel)IBA 01/2017
1	Proteasome InhibitorsIBA 04/2016
1	Proteasome Endopeptidase Complex (Proteasome)IBA 04/2016
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2016
1	Infliximab (Remicade)FDA Link 01/2016
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2016
1	Tamoxifen FDA LinkGeneric 10/2015
1	Immunoglobulin G (IgG)IBA 03/2015
1	InterleukinsIBA 03/2015
1	Messenger RNA (mRNA)IBA 02/2015
1	AntitoxinsIBA 01/2015
1	tofacitinibIBA 09/2014
1	Janus KinasesIBA 09/2014
1	Janus Kinase InhibitorsIBA 09/2014
1	IodineIBA 11/2010
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2006
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 05/2004
1	ElementsIBA 05/2004

Therapy/Procedure

13	Therapeutics 10/2023 - 07/2004
3	Colectomy 01/2021 - 12/2012
2	Hyperbaric Oxygenation 01/2022 - 10/2018
1	Biological Therapy 10/2018
1	Aftercare (After-Treatment) 02/2015
1	Terminal Care (Care, Terminal) 11/2003